Bupropion is an antidepressant medication that is now also used in smoking cessation. Bupropion was first patented by Burroughs Wellcome (now part of GlaxoSmithKline) in 1974. Before 2000, the drug was referred to as amfebutamone. Bupropion has been FDA-approved since 1985.Â The sustained release formula was introduced in 1996.

- The medication is FDA-approved for adult depression, seasonal affective disorder, and smoking cessation.

- Off-label, non-FDA-approved uses include anti-depressant-induced sexual dysfunction, attention-deficit/hyperactivity disorder (ADHD), depression associated with bipolar disorder, and obesity.

- In the pediatric population, bupropion is used off-label for ADHD.